{"product_id":"botox-and-fillers-clinic-kpi-metrics","title":"7 Critical KPIs for Scaling a Botox and Filler Clinic","description":"\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003ch2\u003eKPI Metrics for Botox and Filler Clinic\u003c\/h2\u003e\n\u003cp\u003eTo scale a Botox and Filler Clinic effectively in 2026, you must track capacity utilization, client retention, and profitability metrics like Gross Margin Initial projections show a rapid breakeven in 2 months and a strong Year 1 EBITDA of \u003cstrong\u003e$620,000\u003c\/strong\u003e Focus on maximizing injector efficiency, where Senior RNs aim for 160 treatments monthly Review financial metrics (Gross Margin, Operating Margin) \u003cstrong\u003emonthly\u003c\/strong\u003e and operational metrics (Utilization, Retention Rate) \u003cstrong\u003eweekly\u003c\/strong\u003e Injectable product costs must stay low, targeting \u003cstrong\u003e100% to 120%\u003c\/strong\u003e of revenue as you gain purchasing power This guide defintely details the seven essential metrics to drive growth and manage capacity across your team of seven FTEs\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #6067F2;\"\u003e7 KPIs to Track for \u003c\/span\u003eBotox and Filler Clinic\u003c\/h2\u003e\u003cbr\u003e\n\u003ctable id=\"dwnld_tbl_id\"\u003e\n\u003ctr\u003e\n\u003cth\u003e#\u003c\/th\u003e\n\u003cth\u003eKPI Name\u003c\/th\u003e\n\u003cth\u003eMetric Type\u003c\/th\u003e\n\u003cth\u003eTarget \/ Benchmark\u003c\/th\u003e\n\u003cth\u003eReview Frequency\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003eAverage Treatment Value (ATV)\u003c\/td\u003e\n\u003ctd\u003eRevenue Per Visit\u003c\/td\u003e\n\u003ctd\u003eExceed $460 based on 2026 blended rates\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eInjector Utilization Rate\u003c\/td\u003e\n\u003ctd\u003eStaff Efficiency\u003c\/td\u003e\n\u003ctd\u003eRange from 400% (Junior RN, 2026) to 800% (Medical Director, 2030)\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eInjectable Product Cost %\u003c\/td\u003e\n\u003ctd\u003eCOGS Efficiency\u003c\/td\u003e\n\u003ctd\u003eAim to reduce from 120% (2026) toward 100% (2030)\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eGross Margin %\u003c\/td\u003e\n\u003ctd\u003eProfitability After Direct Costs\u003c\/td\u003e\n\u003ctd\u003eMaintain margins above 860% initially\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eCustomer Acquisition Cost (CAC)\u003c\/td\u003e\n\u003ctd\u003eMarketing Efficiency\u003c\/td\u003e\n\u003ctd\u003eMust be significantly lower than Client Lifetime Value (CLV)\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003eClient Retention Rate (CRR)\u003c\/td\u003e\n\u003ctd\u003eClient Loyalty\u003c\/td\u003e\n\u003ctd\u003eTarget above 70% given recurring treatment nature\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003eTreatments Per FTE\u003c\/td\u003e\n\u003ctd\u003eStaff Productivity\u003c\/td\u003e\n\u003ctd\u003eMust rise from 80 treatments\/FTE (560 treatments \/ 7 FTE in 2026)\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"dwnld_btn_div\"\u003e\u003cbutton id=\"dwnld_btn_id\" class=\"dwnld_btn_clss\"\u003eDownload Table in XLSX\u003c\/button\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e \u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow do we maximize revenue potential without sacrificing service quality?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eMaximizing revenue for your Botox and Filler Clinic hinges on structuring tiered pricing based on injector expertise and aggressively monitoring Average Treatment Value (AOV) driven by cross-selling ancillary aesthetician services. If you're mapping out this structure, understanding \u003ca href=\"\/blogs\/write-business-plan\/botox-and-fillers-clinic\"\u003eWhat Are The Key Steps To Write A Business Plan For Botox And Filler Clinic?\u003c\/a\u003e is crucial first.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eSet Expert Pricing Tiers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePrice services based on injector seniority: MDs command \u003cstrong\u003e35%\u003c\/strong\u003e more than Junior RNs.\u003c\/li\u003e\n\u003cli\u003eUse Junior RNs for routine, high-volume procedures like standard lip flips.\u003c\/li\u003e\n\u003cli\u003eMD time should be reserved for complex facial balancing or initial consultations.\u003c\/li\u003e\n\u003cli\u003eTrack utilization rates for both tiers to ensure optimal scheduling density.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eBoost AOV Via Bundling\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMeasure AOV separately for clients buying only injectables versus those adding aesthetician services.\u003c\/li\u003e\n\u003cli\u003eTarget a \u003cstrong\u003e20%\u003c\/strong\u003e AOV increase by bundling filler with a post-treatment laser package.\u003c\/li\u003e\n\u003cli\u003eIf onboarding takes 14+ days, churn risk rises defintely due to delayed treatment planning.\u003c\/li\u003e\n\u003cli\u003eIdentify the top three cross-sell combinations that boost gross margin per visit.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat is the true cost of delivering a single treatment, and can we lower it?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe true cost of a single treatment is defined by variable product costs, but the \u003cstrong\u003e$14,900\u003c\/strong\u003e monthly fixed overhead demands high volume to achieve profitability. Lowering the cost of goods sold (COGS) for injectables is the primary lever to improve your operating margin.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eGross Margin by Service Type\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eBotox Gross Margin might hit \u003cstrong\u003e75%\u003c\/strong\u003e if product cost is kept under \u003cstrong\u003e25%\u003c\/strong\u003e of the service price.\u003c\/li\u003e\n\u003cli\u003eFiller treatments often yield lower margins, perhaps \u003cstrong\u003e65%\u003c\/strong\u003e, due to higher material costs per syringe administered.\u003c\/li\u003e\n\u003cli\u003eYour main variable costs are the injectable product itself and medical consumables like needles and syringes.\u003c\/li\u003e\n\u003cli\u003eFocus on supplier negotiation to cut product costs by even \u003cstrong\u003e5%\u003c\/strong\u003e; that directly boosts your gross profit dollars.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFixed Overhead Squeeze\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe \u003cstrong\u003e$14,900\u003c\/strong\u003e monthly fixed cost must be covered before you see any operating profit.\u003c\/li\u003e\n\u003cli\u003eIf your blended gross margin is \u003cstrong\u003e68%\u003c\/strong\u003e, you need about \u003cstrong\u003e$21,765\u003c\/strong\u003e in monthly revenue just to cover overhead costs.\u003c\/li\u003e\n\u003cli\u003eThis means you need roughly \u003cstrong\u003e44\u003c\/strong\u003e filler treatments or \u003cstrong\u003e58\u003c\/strong\u003e Botox treatments monthly just to break even, assuming average prices.\u003c\/li\u003e\n\u003cli\u003eIf onboarding takes 14+ days, churn risk rises, making consistent client flow defintely critical. Check \u003ca href=\"\/blogs\/operating-costs\/botox-and-fillers-clinic\"\u003eAre Your Operational Costs For Botox And Filler Clinic Under Control?\u003c\/a\u003e to see how these fixed costs affect your bottom line.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eAre we utilizing our high-cost clinical staff and equipment effectively?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYou must quantify your Injector Utilization Rate against defined capacity targets to ensure high-cost clinical labor isn't sitting idle. If your Medical Director is targeting \u003cstrong\u003e700%\u003c\/strong\u003e utilization by 2026, you need clear metrics tracking treatments per FTE now; this directly impacts profitability, so reviewing \u003ca href=\"\/blogs\/operating-costs\/botox-and-fillers-clinic\"\u003eAre Your Operational Costs For Botox And Filler Clinic Under Control?\u003c\/a\u003e is essential for setting realistic staffing plans.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMeasure Utilization Against Targets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSet the baseline utilization target (e.g., \u003cstrong\u003e700%\u003c\/strong\u003e by 2026).\u003c\/li\u003e\n\u003cli\u003eTrack total treatments administered per injector FTE monthly.\u003c\/li\u003e\n\u003cli\u003eCalculate the revenue generated per utilized hour.\u003c\/li\u003e\n\u003cli\u003eIdentify scheduling gaps where high-cost staff wait for patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eOptimize Staffing Ratios\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDetermine the optimal staff-to-patient ratio for quality service.\u003c\/li\u003e\n\u003cli\u003eIf utilization is low, increase patient flow or reduce clinical FTE count.\u003c\/li\u003e\n\u003cli\u003eHigh utilization means you're defintely maximizing asset value.\u003c\/li\u003e\n\u003cli\u003eFocus on procedure mix to maximize revenue per appointment slot.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow well do we retain clients, and what drives long-term value?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eFor your Botox and Filler Clinic, long-term value hinges on keeping clients coming back for their refresh appointments, which means rigorously tracking Customer Lifetime Value (CLV) against Customer Acquisition Cost (CAC). Monitoring Client Retention Rate (CRR) and Net Promoter Score (NPS) are the essential levers for defintely sustainable growth here.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMeasuring Value vs. Cost\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCalculate CLV based on average client spend over \u003cstrong\u003e24 months\u003c\/strong\u003e of service.\u003c\/li\u003e\n\u003cli\u003eDetermine CAC by dividing total marketing spend by new clients acquired this quarter.\u003c\/li\u003e\n\u003cli\u003eMonitor CRR specifically for Botox refresh cycles, which typically run every \u003cstrong\u003e3 to 6 months\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eIf CLV falls below \u003cstrong\u003e3x CAC\u003c\/strong\u003e, you are spending too much to acquire each new patient.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eGauging Client Sentiment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eUse Net Promoter Score (NPS) surveys immediately after the client's first or second treatment.\u003c\/li\u003e\n\u003cli\u003eA high NPS suggests strong organic referral potential, lowering future acquisition needs.\u003c\/li\u003e\n\u003cli\u003eUnderstand the upfront investment required for opening your clinic; see \u003ca href=\"\/blogs\/startup-costs\/botox-and-fillers-clinic\"\u003eWhat Is The Estimated Cost To Open Your Botox And Filler Clinic?\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003ePromoters (NPS scores of \u003cstrong\u003e9 or 10\u003c\/strong\u003e) are your best source of low-cost, high-quality leads.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e \u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003eTo secure profitability, aggressively manage Injectable Product Costs, aiming to reduce this COGS component from 120% down toward 100% of total revenue.\u003c\/li\u003e\n\n\u003cli\u003eMaximize revenue potential by focusing on increasing the Average Treatment Value (ATV) above $460 while simultaneously achieving a Client Retention Rate (CRR) above 70%.\u003c\/li\u003e\n\n\u003cli\u003eAchieve operational efficiency by tracking the Injector Utilization Rate weekly, ensuring staff meet capacity targets ranging from 400% for junior staff up to 800% for senior injectors.\u003c\/li\u003e\n\n\u003cli\u003eDrive toward the $620,000 Year 1 EBITDA goal by reviewing critical financial metrics like Gross Margin monthly and operational metrics like Utilization weekly.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 1\n: \u003cspan style=\"color: #126CFF;\"\u003eAverage Treatment Value (ATV)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eAverage Treatment Value (ATV) shows how much money you make, on average, every time a client gets a procedure. It’s the core measure of revenue quality per appointment, telling you if clients are buying single units or comprehensive plans. Hitting the \u003cstrong\u003e$460\u003c\/strong\u003e target ATV based on \u003cstrong\u003e2026\u003c\/strong\u003e blended rates is non-negotiable for hitting revenue goals.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows revenue quality, not just appointment volume.\u003c\/li\u003e\n\u003cli\u003eDirectly influences total monthly revenue potential.\u003c\/li\u003e\n\u003cli\u003eHelps you price service packages effectively.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCan hide high client churn if only volume is chased.\u003c\/li\u003e\n\u003cli\u003eDoesn't account for product cost variances between treatments.\u003c\/li\u003e\n\u003cli\u003eA high ATV might result from over-treating, risking client satisfaction.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor specialized aesthetic clinics, ATV varies widely based on service mix. Clinics focusing heavily on high-unit-cost dermal fillers often see ATVs well over \u003cstrong\u003e$700\u003c\/strong\u003e. Your target of \u003cstrong\u003e$460\u003c\/strong\u003e suggests a balanced mix of standard and premium procedures for \u003cstrong\u003e2026\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eBundle services: Sell Botox\/Filler combos instead of single units.\u003c\/li\u003e\n\u003cli\u003eUpsell during consultation: Recommend a second syringe based on anatomy needs.\u003c\/li\u003e\n\u003cli\u003eTier pricing: Introduce premium product options at higher price points.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eATV is simple division: take all the money you brought in from treatments and divide it by how many treatments you actually performed. This tells you the average ticket size for every client visit.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nATV = Total Revenue \/ Total Treatments\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf you project \u003cstrong\u003e560\u003c\/strong\u003e total treatments for \u003cstrong\u003e2026\u003c\/strong\u003e, you need to generate enough revenue to hit the \u003cstrong\u003e$460\u003c\/strong\u003e target. Here’s the quick math: \u003cstrong\u003e$460\u003c\/strong\u003e multiplied by \u003cstrong\u003e560\u003c\/strong\u003e treatments equals the required monthly revenue.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nRequired Revenue = $460 (ATV Target) x 560 (Total Treatments) = $257,600\n\u003c\/div\u003e\n\u003cp\u003eIf your revenue is \u003cstrong\u003e$257,600\u003c\/strong\u003e against \u003cstrong\u003e560\u003c\/strong\u003e treatments, your ATV is exactly \u003cstrong\u003e$460\u003c\/strong\u003e. If revenue hits \u003cstrong\u003e$280,000\u003c\/strong\u003e, your ATV jumps to \u003cstrong\u003e$500\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack ATV daily, not just monthly, to catch dips fast.\u003c\/li\u003e\n\u003cli\u003eAnalyze ATV by injector to spot training gaps or high performers.\u003c\/li\u003e\n\u003cli\u003eEnsure your \u003cstrong\u003e120%\u003c\/strong\u003e product cost doesn't erode ATV gains too much.\u003c\/li\u003e\n\u003cli\u003eMake sure you defintely track the blended rate used for the \u003cstrong\u003e$460\u003c\/strong\u003e target.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 2\n: \u003cspan style=\"color: #126CFF;\"\u003eInjector Utilization Rate\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe Injector Utilization Rate measures how efficiently your medical staff performs treatments relative to their maximum possible workload. This metric tells you if you are maximizing the revenue potential of every licensed injector on payroll. For this clinic, capacity targets vary significantly based on staff seniority and experience level, ranging from \u003cstrong\u003e400%\u003c\/strong\u003e to \u003cstrong\u003e800%\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIdentifies underused, high-cost clinical staff immediately.\u003c\/li\u003e\n\u003cli\u003eDirectly links staffing levels to revenue generation goals.\u003c\/li\u003e\n\u003cli\u003eHelps justify hiring new injectors based on existing capacity strain.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCapacity targets (like \u003cstrong\u003e400%\u003c\/strong\u003e to \u003cstrong\u003e800%\u003c\/strong\u003e) are highly subjective and hard to standardize.\u003c\/li\u003e\n\u003cli\u003eExtremely high utilization can mask burnout or rushed client consultations, hurting retention.\u003c\/li\u003e\n\u003cli\u003eIt doesn't account for non-billable time, like charting or mandatory training.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eBenchmarks here are role-specific, not general industry averages. A \u003cstrong\u003eJunior RN\u003c\/strong\u003e in \u003cstrong\u003e2026\u003c\/strong\u003e might target \u003cstrong\u003e400%\u003c\/strong\u003e utilization, meaning they are performing four times the baseline capacity of a standard shift. Conversely, a seasoned \u003cstrong\u003eMedical Director\u003c\/strong\u003e in \u003cstrong\u003e2030\u003c\/strong\u003e is expected to hit \u003cstrong\u003e800%\u003c\/strong\u003e capacity due to superior speed and procedure complexity. These targets define your operational ceiling for revenue capture.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eStandardize treatment times for common procedures like Botox units.\u003c\/li\u003e\n\u003cli\u003eCross-train staff to handle lower-complexity filler appointments efficiently.\u003c\/li\u003e\n\u003cli\u003eImplement dynamic scheduling to fill gaps created by cancellations instantly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nInjector Utilization Rate = Actual Treatments \/ Maximum Capacity Treatments\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf we set the baseline maximum capacity (100%) for a standard injector shift at \u003cstrong\u003e10 treatments\u003c\/strong\u003e per day, a Junior RN aiming for their \u003cstrong\u003e2026\u003c\/strong\u003e target must achieve \u003cstrong\u003e40 treatments\u003c\/strong\u003e daily (400% utilization). If the clinic averages \u003cstrong\u003e560 treatments\u003c\/strong\u003e per month across \u003cstrong\u003e7 FTEs\u003c\/strong\u003e in 2026, the current daily average is only 4 treatments per FTE, indicating utilization is far below the \u003cstrong\u003e400%\u003c\/strong\u003e goal. We need to find out what the actual maximum capacity is to calculate the true rate, but based on targets, we know we are leaving money on the table.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nIf Max Capacity = 100 Treatments\/Day, and Actual Treatments = 40 Treatments\/Day, Utilization = 40 \/ 100 = 40% (This is the raw ratio before scaling to the 400%-800% target scale).\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSegment utilization by injector role (RN vs. MD) and tenure.\u003c\/li\u003e\n\u003cli\u003eTrack utilization alongside Average Treatment Value (ATV) to avoid low-value volume chasing.\u003c\/li\u003e\n\u003cli\u003eReview utilization weekly; anything below \u003cstrong\u003e350%\u003c\/strong\u003e needs immediate scheduling review.\u003c\/li\u003e\n\u003cli\u003eEnsure capacity definitions account for consultation time, not just procedure time; defintely document this assumption.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 3\n: \u003cspan style=\"color: #126CFF;\"\u003eInjectable Product Cost %\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis metric tracks how much your injectable supplies cost relative to the revenue you generate from treatments. It’s a direct measure of your Cost of Goods Sold (COGS) efficiency for physical products. If this number is above \u003cstrong\u003e100%\u003c\/strong\u003e, you are paying more for the product itself than you are collecting from the client for that service.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows immediate pressure points on gross margin from supply costs.\u003c\/li\u003e\n\u003cli\u003eDirectly measures the effectiveness of volume purchasing agreements.\u003c\/li\u003e\n\u003cli\u003eHelps decide if pricing needs adjusting when supplier costs change.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores injector labor costs, which are a major operational expense.\u003c\/li\u003e\n\u003cli\u003eA very low percentage might signal you are under-pricing your services too aggressively.\u003c\/li\u003e\n\u003cli\u003eIt changes based on the mix of high-cost filler versus lower-cost neurotoxin treatments.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor established aesthetic clinics, product COGS usually sits between \u003cstrong\u003e30% and 50%\u003c\/strong\u003e of revenue, assuming proper service markup. Your starting point of \u003cstrong\u003e120%\u003c\/strong\u003e in 2026 shows you are currently losing money on the product itself before considering overhead. The target of \u003cstrong\u003e100%\u003c\/strong\u003e by 2030 means you must achieve cost parity, but true profitability requires getting well below that threshold, honestly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eEstablish firm volume tiers with primary suppliers to lock in lower per-unit costs.\u003c\/li\u003e\n\u003cli\u003eStandardize treatment protocols to reduce waste and ensure consistent product consumption per procedure.\u003c\/li\u003e\n\u003cli\u003eFocus on increasing the Average Treatment Value (ATV) to improve the denominator in the ratio.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo find this efficiency ratio, you divide the total dollar amount spent on purchasing injectables by the total revenue collected from all services in the same period.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nInjectable Product Cost % = (Injectable Product Costs \/ Total Revenue)\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf your clinic spent \u003cstrong\u003e$120,000\u003c\/strong\u003e on Botox and filler inventory during a month when total service revenue was \u003cstrong\u003e$100,000\u003c\/strong\u003e, the calculation shows immediate product inefficiency. This is the exact situation you face in 2026.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nInjectable Product Cost % = ($120,000 \/ $100,000) = 1.20 or \u003cstrong\u003e120%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack product costs monthly; don't wait for quarterly financial reviews.\u003c\/li\u003e\n\u003cli\u003eModel the exact impact of supplier discounts on the 2026 120% rate.\u003c\/li\u003e\n\u003cli\u003eAudit injector ordering patterns to catch overstocking or misuse defintely.\u003c\/li\u003e\n\u003cli\u003eEnsure your pricing structure explicitly covers the cost of goods plus a healthy markup.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 4\n: \u003cspan style=\"color: #126CFF;\"\u003eGross Margin %\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eGross Margin Percentage shows your profitability after paying for the direct costs tied to delivering the service. For your clinic, this means revenue minus the Cost of Goods Sold (COGS), which is mainly the cost of the injectables and supplies used. This metric tells you how efficiently your core service delivery model is working before you account for rent or administrative staff.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows the raw profitability of each treatment session.\u003c\/li\u003e\n\u003cli\u003eDirectly measures the impact of your injectable purchasing strategy.\u003c\/li\u003e\n\u003cli\u003eHelps set minimum service prices needed to cover direct costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIt ignores all fixed overhead, like clinic lease payments.\u003c\/li\u003e\n\u003cli\u003eIt doesn't account for marketing spend or client acquisition costs.\u003c\/li\u003e\n\u003cli\u003eIf COGS is calculated poorly, this number is useless.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor high-touch aesthetic services, margins should be substantial, but your initial target is exceptionally high: you must maintain margins above \u003cstrong\u003e860%\u003c\/strong\u003e initially. This suggests that your revenue must significantly outpace your direct costs, especially given that your Injectable Product Cost % is projected at \u003cstrong\u003e120%\u003c\/strong\u003e in 2026. You need to review this figure monthly to ensure you are on track to meet that aggressive goal.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDrive Average Treatment Value (ATV) above the \u003cstrong\u003e$460\u003c\/strong\u003e target consistently.\u003c\/li\u003e\n\u003cli\u003eExecute bulk purchasing plans to drive Injectable Product Cost % toward \u003cstrong\u003e100%\u003c\/strong\u003e by 2030.\u003c\/li\u003e\n\u003cli\u003eReview pricing structures monthly against rising product costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate Gross Margin Percentage by taking total revenue, subtracting the direct costs (COGS), and dividing that result by the total revenue. This gives you the percentage of every dollar earned that remains after paying for the product used in the service.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n(Revenue - COGS) \/ Revenue\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay your clinic brings in \u003cstrong\u003e$50,000\u003c\/strong\u003e in revenue for the month, and your direct costs for injectables and supplies (COGS) total \u003cstrong\u003e$5,000\u003c\/strong\u003e. Here is the quick math to find the margin:\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n($50,000 - $5,000) \/ $50,000 = 0.90 or \u003cstrong\u003e90%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf you hit a \u003cstrong\u003e90%\u003c\/strong\u003e margin, you are keeping 90 cents of every dollar before overhead. You need to achieve a margin significantly higher than this, targeting that \u003cstrong\u003e860%\u003c\/strong\u003e benchmark.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack Injectable Product Cost % as a leading indicator of margin health.\u003c\/li\u003e\n\u003cli\u003eIf ATV falls below \u003cstrong\u003e$460\u003c\/strong\u003e, churn risk rises defintely.\u003c\/li\u003e\n\u003cli\u003eEnsure COGS includes all disposables, syringes, and prep materials, not just the active ingredient.\u003c\/li\u003e\n\u003cli\u003eUse utilization rates to ensure high-margin services are prioritized during peak times.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 5\n: \u003cspan style=\"color: #126CFF;\"\u003eCustomer Acquisition Cost (CAC)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCustomer Acquisition Cost (CAC) is the total money spent marketing and selling to get one new client. It directly measures how efficient your marketing dollars are. For this clinic, the critical test is ensuring this cost is \u003cstrong\u003esignificantly lower\u003c\/strong\u003e than the Customer Lifetime Value (CLV), which is the total profit you expect from that client over their relationship with you.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows if marketing spend is generating positive unit economics.\u003c\/li\u003e\n\u003cli\u003eHelps set hard limits on how much you can spend per new patient.\u003c\/li\u003e\n\u003cli\u003eAllows you to compare acquisition efficiency across different marketing channels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIt ignores the quality of the client acquired.\u003c\/li\u003e\n\u003cli\u003eIt can be misleading if marketing spend fluctuates wildly month-to-month.\u003c\/li\u003e\n\u003cli\u003eIt doesn't account for the time lag between spending and revenue realization.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIn elective medical services, a sustainable ratio is often 1:3 (CAC to CLV). If your Average Treatment Value (ATV) target is \u003cstrong\u003e$460\u003c\/strong\u003e, you need clients to return enough times to generate substantial profit beyond that first visit. If your CAC exceeds the revenue from the first visit, you are defintely relying too heavily on future loyalty to justify today’s spend.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIncrease Client Retention Rate (CRR) above the \u003cstrong\u003e70%\u003c\/strong\u003e target to spread acquisition costs wider.\u003c\/li\u003e\n\u003cli\u003eFocus on referrals, which typically have near-zero direct marketing cost.\u003c\/li\u003e\n\u003cli\u003eOptimize injector time to increase the number of treatments per FTE, boosting overall profitability.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" al t=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate CAC by taking all your marketing and sales expenses for a period and dividing that total by the number of new clients you added that same period. This must be done monthly to track trends.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCAC = Total Marketing Spend \/ New Clients Acquired\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf your planned marketing spend in 2026 is \u003cstrong\u003e$12,920\u003c\/strong\u003e monthly, and you successfully onboard \u003cstrong\u003e60\u003c\/strong\u003e new clients that month, here is the resulting CAC. You need to ensure the CLV generated by those 60 clients far outweighs this monthly cost.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCAC = $12,920 \/ 60 New Clients Acquired = $215.33 per New Client\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAttribute all costs, including staff time spent on marketing coordination.\u003c\/li\u003e\n\u003cli\u003eSegment CAC by acquisition source to kill expensive, low-value channels.\u003c\/li\u003e\n\u003cli\u003eIf your CAC is high, immediately review your ATV to ensure the first transaction covers the cost.\u003c\/li\u003e\n\u003cli\u003eTrack CAC against the projected CLV ratio weekly, not just monthly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 6\n: \u003cspan style=\"color: #126CFF;\"\u003eClient Retention Rate (CRR)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eClient Retention Rate (CRR) shows how many existing clients stick around over a specific period. For this clinic, it measures loyalty for repeat injectable services like Botox and fillers. Since treatments are recurring, you defintely need this above \u003cstrong\u003e70%\u003c\/strong\u003e to ensure sustainable revenue.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePredicts stable monthly revenue streams for budgeting.\u003c\/li\u003e\n\u003cli\u003eLowers the pressure on Customer Acquisition Cost (CAC).\u003c\/li\u003e\n\u003cli\u003eIndicates high satisfaction with practitioner skill and results.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDoesn't measure the value of retained clients (ATV could drop).\u003c\/li\u003e\n\u003cli\u003eCan mask service quality dips if clients delay booking, not cancel.\u003c\/li\u003e\n\u003cli\u003eThe formula ignores clients who left but might return after a longer cycle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor elective medical services that require periodic touch-ups, anything below \u003cstrong\u003e60%\u003c\/strong\u003e is a major red flag; you want to be in the \u003cstrong\u003e70%\u003c\/strong\u003e to \u003cstrong\u003e85%\u003c\/strong\u003e range. If your CRR dips below \u003cstrong\u003e70%\u003c\/strong\u003e, you’re spending too much marketing dollars just to replace lost business.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eImplement automated follow-up scheduling 6-8 weeks post-treatment.\u003c\/li\u003e\n\u003cli\u003eCreate tiered loyalty programs based on annual spend thresholds.\u003c\/li\u003e\n\u003cli\u003eEnsure practitioners consistently review and upsell complementary services during consultations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e((Clients End Period - New Clients) \/ Clients Start Period)\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay you started the month with \u003cstrong\u003e500\u003c\/strong\u003e active clients. You acquired \u003cstrong\u003e50\u003c\/strong\u003e new clients during that month. If you ended the month with \u003cstrong\u003e480\u003c\/strong\u003e clients total, you calculate retention like this:\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e((480 - 50) \/ 500) = 430 \/ 500 = \u003cstrong\u003e86%\u003c\/strong\u003e CRR\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e86%\u003c\/strong\u003e retention is excellent, meaning only 14% of your starting base needed replacement.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack CRR monthly, not quarterly, for injectables.\u003c\/li\u003e\n\u003cli\u003eSegment retention by injector to spot training needs fast.\u003c\/li\u003e\n\u003cli\u003eFactor in the time lag between filler appointments (e.g., 6-12 months).\u003c\/li\u003e\n\u003cli\u003eIf CAC is high ($12,920 monthly in 2026), retention must be excellent to cover it.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 7\n: \u003cspan style=\"color: #126CFF;\"\u003eTreatments Per FTE\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTreatments Per FTE measures overall staff productivity by dividing the total monthly treatments performed by the total number of full-time equivalent staff members. It’s a core metric showing how effectively your practitioners are booked and working. If staff numbers grow, this ratio must defintely rise as utilization improves to justify the added payroll expense.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows direct operational efficiency per employee.\u003c\/li\u003e\n\u003cli\u003eHelps justify hiring decisions based on output capacity.\u003c\/li\u003e\n\u003cli\u003eLinks utilization directly to controlling labor costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores the complexity or time required for specific treatments.\u003c\/li\u003e\n\u003cli\u003eCan incentivize practitioners to rush appointments to hit targets.\u003c\/li\u003e\n\u003cli\u003eDoesn't differentiate between clinical FTEs and support staff FTEs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor specialized aesthetic clinics, TPFTE varies based on service mix and practitioner seniority. A high TPFTE suggests excellent scheduling and high demand for quick procedures. You need to track this against the Injector Utilization Rate to set realistic staffing goals for your team.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eBoost the Injector Utilization Rate to ensure practitioners aren't idle.\u003c\/li\u003e\n\u003cli\u003eStreamline patient intake and check-out processes to reduce non-treatment time.\u003c\/li\u003e\n\u003cli\u003eSchedule more frequent, lower-value treatments to increase total volume quickly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo calculate Treatments Per FTE, divide the total number of treatments administered in a month by the total full-time equivalent staff count. This shows the average workload carried by each staff member.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nTreatments Per FTE = Total Monthly Treatments \/ Total FTE\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eUsing the 2026 projections, we see \u003cstrong\u003e560\u003c\/strong\u003e total monthly treatments handled by \u003cstrong\u003e7\u003c\/strong\u003e full-time equivalent staff members. This gives us a baseline productivity number we must improve upon as the business scales.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nTreatments Per FTE = 560 Treatments \/ 7 FTE = \u003cstrong\u003e80\u003c\/strong\u003e Treatments Per FTE\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack this metric monthly to catch scheduling dips immediately.\u003c\/li\u003e\n\u003cli\u003eSegment the calculation by practitioner seniority level for fair comparison.\u003c\/li\u003e\n\u003cli\u003eEnsure your FTE count only includes staff actively performing treatments.\u003c\/li\u003e\n\u003cli\u003eIf Average Treatment Value (ATV) rises, TPFTE can afford to dip slightly, but only if margins hold.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49303800021235,"sku":"botox-and-fillers-clinic-kpi-metrics","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/botox-and-fillers-clinic-kpi-metrics.webp?v=1782677093","url":"https:\/\/financialmodelslab.com\/products\/botox-and-fillers-clinic-kpi-metrics","provider":"Financial Models Lab","version":"1.0","type":"link"}